why choose us

Clinical Trials Search

Showing 13,550 of 132,366 result(s)
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

Status: Completed

Condition: Non-small Cell Lung Cancer

Interventions: Administered intravenously (IV) every 3 weeks (Q3W)

Date: 2023-03-23

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

Status: Completed

Condition: COVID-19

Interventions: NP-101 is an organically derived, GMP manufactured product covered under IND #152687.

Date: 2023-03-23

Effects Of Income Supplements On 30-Day Readmissions For Vulnerable Older Adults

Status: Completed

Condition: Patient Readmission

Interventions: $300 income supplement

Date: 2023-03-23

Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma

Status: Completed

Condition: Multiple Myeloma

Interventions: Cycles 1, 3, 5, 7, etc. (odd numbered cycles): 1.9 mg;kg IV on Day 1 (28-day cycles)

Date: 2023-03-23

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Status: Completed

Condition: Anatomic Stage I Breast Cancer AJCC v8

Interventions: Given IV

Date: 2023-03-23

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Status: Completed

Condition: Central Nervous System Neoplasms

Interventions: Autologous T cells transduced with a lentiviral vector expressing a B7-H3-CAR with a CD28z signaling domain and 41BB ligand (B7-H3-CAR T cells).

Date: 2023-03-23

A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures

Status: Completed

Condition: Bladder Spasms

Interventions: Intravenous infusion, load 50 mg;Kg with infusion of 15 mg;Kg;hour

Date: 2023-03-23

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Status: Completed

Condition: Colon Cancer

Interventions: Participants will be treated with the study drugs until radiological evidence of disease progression or until treatment discontinuation secondary to a

Date: 2023-03-23

Oncology Care at Home for BMT and CAR-T

Status: ACTIVE_NOT_RECRUITING

Condition: Leukemia

Interventions: This study uses the BioIntelliSense BioButton Rechargeable for RPM, in combination with the BioSync mobile app on participants' mobile phones for

Date: 2023-03-23

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

Status: NOT_YET_RECRUITING

Condition: Systemic Lupus Erythematosus

Interventions: Hydroxychloroquine 200mg capsules.
Administered orally.

Date: 2023-03-23